A STUDY ON OUTCOMES OF VARIOUS TREATMENT REGIMENS IN DRUG- RESISTANT TUBERCULOSIS
Main Article Content
Keywords
Drug-Resistant Tuberculosis, Treatment Outcome
Abstract
Background:
Drug-resistant tuberculosis (DR-TB) poses a significant challenge to global public health due to its complexity in treatment and the emergence of extensively drug-resistant strains. Conventional treatment protocols have shown varying success rates, necessitating exploration into alternative regimens. Understanding the outcomes of these diverse treatment approaches is crucial for optimizing patient care and combating the spread of resistant strains.
Aims & Objectives:
This study aims to investigate the outcomes of different treatment regimens employed for DR-TB.
Methodology:
This is a record-based study in a Government Medical college in Maharashtra during the year 2020 to 2022. All adult drug resistant TB cases registered were included, giving a sample size of 258. The outcomes of all regimens were examined.
Results:
Out of the total 258cases, 136(52.71%) were males and 122(47.28%) were females. Majority of them 90 (34.88%) belonged to age group of 21 to 30 years. The treatment outcomes were as follows: Out of the total 258 cases, 107(41.47%) were cured , 55(21.31%) completed treatment, 3(1.16%) were treatment failed, 6(2.32%) were lost to follow up, 45(17.44%) expired before treatment completion, 41(15.89%) required change of regimen.
Conclusion:
Optimizing treatment strategies for DR-TB is essential for improving patient outcomes, reducing transmission, and addressing the global burden of tuberculosis.
References
2. Seung KJ, Keshavjee S, Rich ML. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr; 27;5(9):1-20.
3. Definitions and reporting framework for tuberculosis–2013 revision: updated December 2014 and January 2020. World Health Organization; 2013.
4. Hamdouni ME, Bourkadi JE, Benamor J et al. Treatment outcomes of drug resistant tuberculosis patients in Morocco: Multi-centric prospective study.BMC infectious diseases 2019;19(316):1-7.
5. Pederson OS, Holmgaard FB, Mikkelsen MKD, Et al.Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis. Journal of Infection 2023;87(3):177-189.
6. Lecai J, Mijiti P, Chuangyue H et al.Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study. Frontier Public Health 2023 Jun 2023; 11:1-9.
7. Singh A,Prasad R,Kushwaha RAS et al.Treatment outcome of multidrug-resistant tuberculosis with modified DOTS-plus strategy: A 2 years’ experience.Lung India 2019 Sept-Oct; 36(5):384-392.
8. Bastos ML, Cosme LB, Fregona G et al.Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.BMC infectious diseases 2017;17(718):1-12.
9. Koirala S. Borisov B,Danilac E et al. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort. Pulmonology Journal. 2021: 27:403-412.
10. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022update. Geneva: World Health Organization; 2022.
11. Rich ML, Khan U, Zeng C et al.Outcome of WHO-conforming, longer, all-oral multidrug resistant TB regimens and analysis implications. Int J Tuberc Lung Dis 2023; 27(6):451-457.
12. Mase SR,Chorbs T. Treatment of Drug-Resistant Tuberculosis.Clinical chest med. 2019 Dec;40(4):775-795.
13. Shetty NS, Bodhanwala M,Shah I.Outcome of drug resistant tuberculosis in Indian Children.Tropical Doctor 2022;52(1):90-94.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Abhijeet Yadav
Associate Professor at Department of Respiratory Medicine, Vilasrao Deshmukh Government Medical college, Latur
Dr. Vivekanand N. Waghmare
Professor at Department of Respiratory Medicine, Vilasrao Deshmukh Government Medical college, Latur
Dr. Sharad B Sable
Assistant Professor at Department of Respiratory Medicine, Vilasrao Deshmukh Government Medical college, Latur